4Bonnet MC,Dutta A.World wide experience with inactivated poliovirus vaccine.Vaccine,2008,26(39):4978-4983.
5Introduction of inactivated poliovirus vaccine into oral poliovirus vaccine-using countries.Wkly Epidemiol Rec,2003,78 (28):241-250.
6Global Polio Eradication Initiative.Polio Eradication and endgame strategic plan 2013-2018[EB/OL].[2013-03-29].http://www.polioeradication.org/Resourcelibrary/Strategyandwork.aspx.
7Polio vaccines and polio immunization in the pre-eradication era:WHO position paper.Wkly Epidemiol Rec,2010,85 (23):213-228.
8Wattigney WA,Mootrey GT,Braun MM,et al.Surveillance for poliovirus vaccine adverse events,1991 to 1998:impact of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine.Pediatrics,2001,107 (5):E83.
9Pietrzyk JJ,Wysocki J,Pejcz J,et al.Safety and immunogenicity of a DTaP-IPV (Vero) (serum-free) combination vaccine in comparison to DTaP-IPV (Mkc) when administered simultaneously with Haemophilus influenzae type B conjugate vaccine (PRP-T)in children at 2,3.5,5 and 16 months of age.Vaccine,2008,26(41):5296-5303.
10Macias M,Lanata CF,Zambrano B,et al.Safety and immunogenicity of an investigational fully liquid hexavalent DTaPIPV-Hep B-PRP-T vaccine at two,four and six months of age compared with licensed vaccines in Latin America.Pediatr Infect Dis J,2012,31 (8):e126-132.
